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Elevation in liver enzymes can be due to a variety 
of reasons such as toxins, drugs, autoimmune 
process, sepsis, malignant infiltration, alcoholic 
hepatitis, viral hepatitis, and other causes. In this 
case study, our patient presented with an 
obstructive pattern of liver test abnormalities. The 
patient demonstrated alkaline phosphatase levels 
>1000, with AST and ALT levels <200. His T-
bilirubin initially was 1.5 and increased to 12.4 by 
the end of his hospital stay. Workup to exclude 
other causes of liver injury was performed and 
eventually a liver biopsy was needed to establish 
etiology. The biopsy revealed a malignant 
infiltration of likely Peripheral T-Cell Lymphoma. 
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History of Present Illness:
• A 65 year old male from a long term care facility 
presented with decreased responsiveness, fever 
and hypotension. His PMH included 
cerebrovascular accident, cerebral aneurysm, 
hyperlipidemia, hypertension, hypothyroidism, 
seizure disorder, and malignant tumor of the 
larynx status post chronic tracheostomy. 
• On physical exam his abdomen was soft, non-
tender, with normal bowel sounds. His only 
complaint was  increased respiratory secretions. 
He was found to have severe sepsis with septic 
shock secondary to pneumonia and bacteriuria.
Labs: Liver function tests revealed a total bilirubin 
of 2.2, direct bilirubin of 1.5, alkaline phosphatase 
630, ALT 41, AST 66, and a GGTP of 616. An 
acute hepatitis panel was negative.
Imaging: 
• A CT scan with oral and IV contrast of his chest, 
abdomen and pelvis demonstrated that the liver 
was within normal limits. 
• An abdominal ultrasound showed that the liver 
was of normal size and echotexture, with no 
evidence of cholecystitis. An acute hepatitis 
panel was negative. 
• A repeat abdominal ultrasound, 5 days later, 
demonstrated that the gallbladder wall was 
borderline diffusely thickened measuring 3.0 cm 
– an increase from the prior study where it 
measured 1.5 mm. An ERCP showed no 
evidence of choledocholithiasis or extrinsic 
compression of the common bile duct. 
• A repeat CT scan revealed a hypodense lesion 
in the inferior right hepatic lobe density series 
and splenic enlargement with multiple masses.
Hospital Course:  
• The patient was admitted to the hospital for 
septic shock, pneumonia, and elevated LFT’s. 
He was treated with antibiotics. His liver 
function tests continued to trend upward in an 
obstructive pattern with no obvious etiology. 
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• Thus, a liver biopsy was performed. 
• He eventually was found to have MRSA 
bacteremia and  required vasopressor support in 
the ICU. He also progressed to hepatic failure 
and Comfort measures were initiated based on 







• Peripheral T-Cell Lymphomas are a group of 
aggressive neoplasms which are grouped under 
Non-Hodgkin Lymphomas. The most common 
subtype is Peripheral T- Cell Lymphoma, Not 
otherwise specified, 1, 2.
• Pathology  from the  patient’s core liver biopsy 
revealed involvement of a CD 30 Peripheral T 
Cell Lymphoma (NOS), however, hepatic 
involvement by an ALK negative Anaplastic T 
Cell Lymphoma could not be excluded. 
• This patient presented with extra-nodal 
involvement. His elevated LFT’s and 
hyperbilirubinemia were likely secondary to this 
neoplastic process. The source of the patient’s  
malignancy was  unknown. 
• T-Cell Lymphomas are fast growing and  usually 
present as disseminated disease  and  are 
clinically aggressive with a dismal prognosis. 3
• Treatment  options include  Chemotherapy 
(Cyclophosphamide, Doxorubicin, Vincristine) 
and Prednisone. However, in recent years , there 
are a number of novel treatment agents which 
hold some promise for improving outcomes. 4
• This case report illustrates an uncommon cause 
of elevated liver function tests. It is important 
for clinicians to be mindful of rarer causes of 
hepatic dysfunction.
• It is imperative to identify T-Cell  Lymphoma 
early and initiate aggressive measures 
immediately to prevent poor outcomes. 
• Further research is needed to aid in 
classification, prognostication, and management 
of T-Cell Lymphomas. 
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